Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Epilepsy Research

• Publication date

  2002-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0920-1211(02)00076-1PMID 12151125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition or enhancement of kindling evolution by antiepileptics

  2005cited by this paper
• Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.

  2003cited by this paper
• Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy.

  2002cited by this paper
• Delayed Sclerosis, Neuroprotection, and Limbic Epileptogenesis After Status Epilepticus in the Rat

  2002cited by this paper
• Effects of the Novel Antiepileptic Drug Levetiracetam on Spontaneous Recurrent Seizures in the Rat Pilocarpine Model of Temporal Lobe Epilepsy

  2002cited by this paper
• Does convulsive status epilepticus (SE) result in cerebral damage or affect the course of epilepsy--the epidemiological and clinical evidence?

  2002cited by this paper
• Neurobiology of epileptogenesis in the temporal lobe.

  2002cited by this paper
• Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.

  2001cited by this paper
• Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats

  2001cited by this paper
• Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.

  2001cited by this paper
• Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta‐Analysis of Controlled Trials

  2001cited by this paper
• Tiagabine treatment and DNA damage in rat astrocytes: an in vitro study by comet assay.

  2001cited by this paper
• Anticonvulsant action and long-term effects of gabapentin in the immature brain.

  2001cited by this paper
• Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.

  2001cited by this paper
• Topiramate blocks perinatal hypoxia‐induced seizures in rat pups

  2001cited by this paper
• Lamotrigine Treatment During Amygdala‐Kindled Seizure Development Fails to Inhibit Seizures and Diminishes Subsequent Anticonvulsant Efficacy

  2000cited by this paper
• Felbamate in Experimental Model of Status Epilepticus

  2000cited by this paper
• A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat.

  2000cited by this paper
• Dose‐dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat

  2000cited by this paper
• Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia.

  2000cited by this paper
• The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats.

  2000cited by this paper
• Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils.

  2000cited by this paper
• Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam.

  2000cited by this paper
• Anesthetic Effects on Cerebral Metabolic Rate Predict Histologic Outcome from Near-complete Forebrain Ischemia in the Rat

  2000cited by this paper
• Protective effect of etomidate on kainic acid-induced neurotoxicity in rat hippocampus.

  2000cited by this paper
• Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.

  2000cited by this paper
• Neuroprotective activity of tiagabine in a focal embolic model of cerebral ischemia.

  2000cited by this paper
• Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus.

  1999cited by this paper
• The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

  1999cited by this paper
• Valproate robustly enhances AP-1 mediated gene expression.

  1999cited by this paper
• Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat.

  1999cited by this paper
• Halothane as a Neuroprotectant During Constant Stimulation of the Perforant Path

  1999cited by this paper
• Different mechanisms of protection against apoptosis by valproate and Li+.

  1999cited by this paper
• Topiramate reduces neuronal injury after experimental status epilepticus.

  1999cited by this paper
• Isoflurane Delays but Does Not Prevent Cerebral Infarction in Rats Subjected to Focal Ischemia

  1999cited by this paper
• Anticonvulsant Activity of PNU‐151774E 1 in the Amygdala Kindled Model of Complex Partial Seizures

  1999cited by this paper
• Comparison of valproate and phenobarbital treatment after status epilepticus in rats

  1998cited by this paper
• Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization.

  1998cited by this paper
• Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy.

  1998cited by this paper
• Risk of unprovoked seizure after acute symptomatic seizure: Effect of status epilepticus

  1998cited by this paper
• Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

  1998cited by this paper
• Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats.

  1998cited by this paper
• PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat.

  1998cited by this paper
• Anticonvulsant and Neuronal Protective Effects of Propofol on Experimental Status Epilepticus

  1998cited by this paper
• Antiepileptic effects of topiramate on amygdaloid kindling in rats.

  1998cited by this paper
• Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin.

  1997cited by this paper
• BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.

  1997cited by this paper
• Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.

  1997cited by this paper
• Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures.

  1997cited by this paper
• Protective Effect of Zonisamide, an Antiepileptic Drug, Against Transient Focal Cerebral Ischemia with Middle Cerebral Artery Occlusion‐Reperfusion in Rats

  1997cited by this paper
• Propofol neuroprotection in a rat model of ischaemia reperfusion injury.

  1997cited by this paper
• Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study.

  1997cited by this paper
• Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat.

  1997cited by this paper
• Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis.

  1997cited by this paper
• Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system.

  1996cited by this paper
• The neuroprotective effects of gamma-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations.

  1996cited by this paper
• Topiramate: a potent anticonvulsant in the amygdala-kindled rat

  1996cited by this paper
• Neuroprotection with felbamate: a 7- and 28-day study in transient forebrain ischemia in gerbils.

  1996cited by this paper
• Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala.

  1996cited by this paper
• Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus.

  1996cited by this paper
• Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia.

  1996cited by this paper
• Anticonvulsant Effects of Tigabine, a New Antiepileptic Drug: The Profile of Action in the Rat Kindling Model of Epilepsy.

  1996cited by this paper
• Neuroprotective effects of felbamate on global ischaemia in Mongolian gerbils.

  1996cited by this paper
• Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.

  1996cited by this paper
• A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia

  1996cited by this paper
• Effect of 2,6-diisopropylphenol on the delayed hippocampal cell loss following transient forebrain ischemia in the gerbil.

  1996cited by this paper
• Electroencephalographic Burst Suppression Is Not Required to Elicit Maximal Neuroprotection from Pentobarbital in a Rat Model of Focal Cerebral Ischemia

  1996cited by this paper
• Analyses of the molecular basis of kindling development

  1995cited by this paper
• Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.

  1995cited by this paper
• Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study.

  1995cited by this paper
• Screening for mutations at codon 717 of the amyloid precursor protein gene in Alzheimer's disease

  1995cited by this paper
• Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.

  1995cited by this paper
• Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus

  1995cited by this paper
• Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum

  1995cited by this paper
• Cerebroprotective effect of lamotrigine after focal ischemia in rats.

  1995cited by this paper
• Phenobarbital modifies seizure‐related brain injury in the developing brain

  1994cited by this paper
• Stimulation-dependent effect of antiepileptic drugs in amygdala kindled rats on both seizure score and duration of afterdischarges.

  1994cited by this paper
• Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents.

  1994cited by this paper
• Hippocampal kindling protects several structures from the neuronal damage resulting from kainic acid-induced status epilepticus.

  1994cited by this paper
• Postischemic diazepam is neuroprotective in the gerbil hippocampus.

  1994cited by this paper
• Oxcarbazepine: Preclinical Anticonvulsant Profile and Putative Mechanisms of Action

  1994cited by this paper
• Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats.

  1994cited by this paper
• Sevoflurane and Halothane Reduce Focal Ischemic Brain Damage in the Rat: Possibloe Influence on Thermoregulation

  1993cited by this paper
• Anticonvulsant Effect of Topiramate [2, 3:4, 5‐bis‐O‐(1‐methylethylidene‐β‐D‐fructopyranose sulfate] on Amygdaloid Kindled Seizures in the Cat

  1993cited by this paper
• Protective effect of clonazepam on ischemic brain damage induced by 10-minute bilateral carotid occlusion in Mongolian gerbils.

  1993cited by this paper
• Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia‐ischemia

  1993cited by this paper
• National General Practice Study of Epilepsy (NGPSE)

  1992cited by this paper
• Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital

  1992cited by this paper
• A Neuropharmacological Evaluation of Felbamate as a Novel Anticonvulsant

  1992cited by this paper
• The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats.

  1992cited by this paper
• Development and Reversal of Contingent Inefficacy and Tolerance to the Anticonvulsant Effects of Carbamazepine

  1991cited by this paper
• Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy

  1991cited by this paper
• Postischemic seizures and necrotizing ischemic brain damage

  1991cited by this paper
• The effect of lamotrigine upon development of cortical kindled seizures in the rat.

  1991cited by this paper
• Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells

  1991cited by this paper
• Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy.

  1991cited by this paper
• Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path.

  1991cited by this paper
• Anticonvulsant effects of zonisamide and phenytoin on seizure activity of the feline visual cortex.

  1990cited by this paper
• Anticonvulsant Drugs Selectively Affect Kindled and Penicillin Epilepsy, Especially During Seizure‐Prone Sleep or Awakening States in Cats

  1989cited by this paper
• Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.

  1989cited by this paper

• Pentylenetetrazole-Induced Seizures in Wistar Male Albino Rats with Reference to Glutamate Metabolism

  2024cites this paper
• Robotic assessment of sensorimotor and cognitive deficits in patients with temporal lobe epilepsy.

  2024cites this paper
• Neuroprotective properties of antiepileptics: what are the implications for psychiatric disorders?

  2023cites this paper
• Centella asiatica (Gotu kola) leaves

  2021cites this paper
• SGK1.1 limits brain damage after status epilepticus through M current-dependent and independent mechanisms.

  2021cites this paper
• Neuronal kinase SGK1.1 protects against brain damage after status epilepticus

  2020cites this paper
• Role of Monoaminergic Systems of the CNS in Different Periods after Status Epilepticus and Its Relation to Cerebral Hemodynamics

  2019cites this paper
• The Utility of the Repeatable Battery of Neuropsychological Status in Patients with Temporal and Non-temporal Lobe Epilepsy.

  2019cites this paper
• Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy

  2018cites this paper
• Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress

  2018cites this paper
• Taurine Protects from Pentylenetetrazole-Induced Behavioral and Neurochemical Changes in Zebrafish

  2018cites this paper
• Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long‐term consequences induced by lithium‐pilocarpine status epilepticus

  2018cites this paper
• Neuropharmacological and neuroprotective activities of some metabolites produced by cell suspension culture of Waltheria americana Linn.

  2017cites this paper
• Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs

  2016cites this paper
• Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers.

  2015cites this paper
• Neuroprotective agents and modulation of temporal lobe epilepsy.

  2015cites this paper
• Prospects of epileptogenesis prevention

  2015cites this paper
• In vivo evaluation of anticonvulsant and antioxidant effects of phenobarbital microemulsion for transdermal administration in pilocarpine seizure rat model.

  2015cites this paper
• Alteration of pentylenetetrazole-induced seizure threshold by chronic administration of ginger (Zingiber officinale) extract in male mice

  2015cites this paper
• Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?

  2014cites this paper
• Estudo das relações entre populações celulares, expressão de aquaporina-4 e sulfato de condroitina com o tempo de relaxamento e a taxa de transferência de magnetização no hipocampo de pacientes com epilepsia do lobo temporal farmacorresistente

  2014cites this paper
• Acute administration of ginger (Zingiber officinale rhizomes) extract on timed intravenous pentylenetetrazol infusion seizure model in mice.

  2014cites this paper
• Gabapentin is neuroprotective through glutamate receptor-independent mechanisms in staurosporine-induced apoptosis of cultured rat cerebellar neurons

  2013cites this paper
• GABAPENTIN IS NEUROPROTECTIVE THROUGH GLUTAMATE RECEPTOR INDEPENDENT MECHANISMS IN STAUROSPORINEINDUCED APOPTOSIS OF CULTURED RAT

  2013cites this paper
• Discontinuation of AEDs: When and how?

  2013cites this paper
• Selected classical and novel antiepileptic drugs – mechanisms of action, neuroprotection, and effectiveness in epileptic and non-epileptic conditions

  2013cites this paper
• Using Caenorhabditis elegans to fight human neurodegenerative diseases

  2013cites this paper
• INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Effect of Centella asiatica (Gotu kola) on the antioxidant enzyme activities and glutathione levels in different regions of rat brain during pentylenetetrazole-induced epilepsy

  2013cites this paper
• When and how to stop antiepileptic drugs

  2013cites this paper
• Effect of topiramate on interleukin 6 expression in the hippocampus of amygdala-kindled epileptic rats

  2013cites this paper
• Increased Metallothionein I/II Expression in Patients with Temporal Lobe Epilepsy

  2012cites this paper
• New approach to predicting proconvulsant activity with the use of Support Vector Regression

  2012cites this paper
• Changes of glucocorticoid receptor mRNA expression in basolateral amygdale-kindled rats.

  2011cites this paper
• Aus dem Department für Veterinärwissenschaften der Tierärztlichen Fakultät der Ludwig-Maximilians-Universität München

  2011cites this paper
• AED discontinuation may not be dangerous in seizure-free patients

  2011cites this paper
• Hydroalcoholic extract of Zizyphus jujuba ameliorates seizures, oxidative stress, and cognitive impairment in experimental models of epilepsy in rats.

  2011cites this paper
• TRENDS AND STRATEGY TOWARDS THERAPIES FOR STATUS EPILEPTICUS: A DECISIVE REVIEW

  2011cites this paper
• Myo-inositol treatment prevents biochemical changes triggered by kainate-induced status epilepticus.

  2010cites this paper
• Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice.

  2010cites this paper
• Pharmacological Management of Seizures and Status Epilepticus in Critically Ill Patients

  2010cites this paper
• Neuroprotective Effects of IGF-I Following Kainic Acid-Induced Hippocampal Degeneration in the Rat

  2010cites this paper
• Evaluation of the anticonvulsant effect of Centella asiatica (gotu kola) in pentylenetetrazol-induced seizures with respect to cholinergic neurotransmission.

  2010cites this paper
• Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

  2010cites this paper
• Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.

  2009cites this paper
• てんかんにおけるグルタミン酸受容体、特にAMPA/KA受容体の意義と新規抗てんかん薬トピラマートの抗てんかん作用

  2009cites this paper
• Neuropathology in Drosophila Mutants With Increased Seizure Susceptibility

  2008influential citation
• Treatment of Lithium-Pilocarpine Induced Status Epilepticus Rat Models According to EEG Stage

  2008cites this paper
• [Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives].

  2007cites this paper
• Neuroprotective effects of some newer and potential antiepileptic drugs

  2007influential citation
• Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.

  2007cites this paper
• Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.

  2006cites this paper
• Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening.

  2006cites this paper
• Histaminergic Neurons Protect the Developing Hippocampus from Kainic Acid-Induced Neuronal Damage in an Organotypic Coculture System

  2006cites this paper
• Effects of the Novel Antiepileptic Drug Lacosamide on the Development of Amygdala Kindling in Rats

  2006cites this paper
• Antiepileptic drugs and neuroprotection: current status and future roles.

  2005cites this paper
• A Spontaneous Recurrent Seizure Bioassay for Anti-Epileptogenic Molecules

  2005cites this paper
• Neuroprotection possibilities in epileptic children.

  2005cites this paper
• Glutamate and Neurodegeneration

  2005cites this paper
• Antiepileptic Effects of Botulinum Neurotoxin E

  2005cites this paper
• Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.

  2005influential citation
• Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat.

  2005cites this paper
• Should Antiepileptic Drugs Be Withdrawn in Seizure-Free Patients?

  2004cites this paper
• New horizons in the development of antiepileptic drugs: the search for new targets.

  2004cites this paper
• Progression of Brain Damage after Status Epilepticus and Its Association with Epileptogenesis: A Quantitative MRI Study in a Rat Model of Temporal Lobe Epilepsy

  2004cites this paper
• The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions

  2004cites this paper
• Implementing a bioassay to screen molecules for antiepileptogenic activity: chronic pilocarpine versus subdudral haematoma models.

  2004cites this paper
• Primary prevention of epilepsy in patients with different epileptogenic conditions

  2004cites this paper
• Atipamezole, an α2-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats

  2004cites this paper
• Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat.

  2004cites this paper
• Epilepsy induced by extended amygdala-kindling in rats: lack of clear association between development of spontaneous seizures and neuronal damage.

  2004cites this paper
• Striking Differences in Individual Anticonvulsant Response to Phenobarbital in Rats with Spontaneous Seizures after Status Epilepticus

  2004cites this paper
• Laboratory animal models of temporal lobe epilepsy.

  2004cites this paper
• Ist Epilepsie eine progrediente Erkrankung?

  2003cites this paper
• Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats.

  2003cites this paper
• Expression and activation of caspase 3 following status epilepticus in the rat

  2003cites this paper
• Long‐term Pregabalin Treatment Protects Basal Cortices and Delays the Occurrence of Spontaneous Seizures in the Lithium‐Pilocarpine Model in the Rat

  2003cites this paper
• Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.

  2003cites this paper
• Role of Neuronal Loss in the Pathogenesis of Recurrent Spontaneous Seizures

  2003cites this paper
• Drug-mediated neuroprotection and antiepileptogenesis: Animal data

  2002cites this paper
• Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection.

  2002cites this paper
• Drug-mediated neuroprotection and antiepileptogenesis

  2002cites this paper
• Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.

  2002cites this paper
• Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy.

  2002cites this paper